PHARMAPLAN @TRIPLAN
We welcome PHARMAPLAN as a new sister company under the umbrella of our parent company, TTP AG.
With the acquisition of the four companies in Belgium, Germany, France and Switzerland from NNE A/S, which has been effective since April 1, 2019, we have gained important expertise: PHARMAPLAN enjoys the highest reputation for focused pharmaceutical engineering in GMP-regulated areas such as solid oral dosage forms or fill & finish. At the same time, we are positioning ourselves more broadly and closer to our customers in the European core market with around 900 employees at 18 locations – and cover the entire value chain for the process industry through to larger EPCMQV projects even more convincingly.
We are convinced that, together with PHARMAPLAN, we can continuously improve our services, whether this involves expanded industry expertise, optimized project processes or the fulfillment of increasingly demanding documentation and regulatory requirements. We are united by a shared understanding of quality and innovation as well as the willingness of our teams of experts to share knowledge and learn from each other.
